Expression levels of a kinesin-13 microtubule depolymerase modulates the effectiveness of anti-microtubule agents.
Chemotherapeutic drugs often target the microtubule cytoskeleton as a means to disrupt cancer cell mitosis and proliferation. Anti-microtubule drugs inhibit microtubule dynamics, thereby triggering apoptosis when dividing cells activate the mitotic checkpoint. Microtubule dynamics are regulated by m...
Main Authors: | Gregory V Schimizzi, Joshua D Currie, Stephen L Rogers |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-06-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2894863?pdf=render |
Similar Items
-
Structural Model for Tubulin Recognition and Deformation by Kinesin-13 Microtubule Depolymerases
by: Ana B. Asenjo, et al.
Published: (2013-03-01) -
The microtubule-binding protein Cep170 promotes the targeting of the kinesin-13 depolymerase Kif2b to the mitotic spindle
by: Welburn, Julie P. I., et al.
Published: (2013) -
Electrostatically biased binding of kinesin to microtubules.
by: Barry J Grant, et al.
Published: (2011-11-01) -
Cryo-EM reveals the structural basis of microtubule depolymerization by kinesin-13s
by: Matthieu P.M.H. Benoit, et al.
Published: (2018-04-01) -
Characterization of Motility Properties of Kinesin-Driven Microtubules Towards Nano-Scale Transporter: Focusing on Length of Microtubules and Kinesin Density
by: Shukei SUGITA, et al.
Published: (2008-10-01)